aLaboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, MD;
bCritical Care Medicine Department, National Institutes of Health (NIH) Clinical Center, Bethesda, MD; and
cRadiology and Imaging Sciences, National Institutes of Health (NIH) Clinical Center, Bethesda, MD;
Correspondence to: Colleen M. Hadigan, MD, MPH, Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), 10 Center Drive, 11C0103, Bethesda, MD 20892 (e-mail: [email protected]).
Supported by the National Institutes of Health through the National Institute of Allergy and Infectious Diseases Intramural Research Program and the National Institutes of Health Clinical Center.
The authors have no conflicts of interest to disclose.
The abstract for this article was presented at the International Workshop on Comorbidities and Adverse Drug Reactions in HIV held virtually on December 1, 2020.
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Web site (www.jaids.com).
